126 related articles for article (PubMed ID: 11550158)
1. Lipid-associated sialoprotein in the cerebrospinal fluid: association with brain malignancies.
Katopodis N; Glantz MJ; Kim L; Dafni U; Wu JK; Perides G
Cancer; 2001 Aug; 92(4):856-62. PubMed ID: 11550158
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
3. Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors.
Ballester LY; Lu G; Zorofchian S; Vantaku V; Putluri V; Yan Y; Arevalo O; Zhu P; Riascos RF; Sreekumar A; Esquenazi Y; Putluri N; Zhu JJ
Acta Neuropathol Commun; 2018 Aug; 6(1):85. PubMed ID: 30170631
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.
Cinque P; Brytting M; Vago L; Castagna A; Parravicini C; Zanchetta N; D'Arminio Monforte A; Wahren B; Lazzarin A; Linde A
Lancet; 1993 Aug; 342(8868):398-401. PubMed ID: 8101902
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.
Shalaby T; Grotzer MA
Int J Mol Sci; 2015 Dec; 16(12):29103-19. PubMed ID: 26690130
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
Verheul C; Kleijn A; Lamfers MLM
Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
[TBL] [Abstract][Full Text] [Related]
8. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Friedberg MH; Glantz MJ; Klempner MS; Cole BF; Perides G
Cancer; 1998 Mar; 82(5):923-30. PubMed ID: 9486583
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay of insulin-like growth factors I and II in the cerebrospinal fluid of patients with pituitary and other central nervous system tumors.
Glick RP; Unterman TG
Neurosurgery; 1995 Mar; 36(3):556-63; discussion 563-4. PubMed ID: 7753356
[TBL] [Abstract][Full Text] [Related]
10. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
Bach F; Soletormos G; Dombernowsky P
J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
[TBL] [Abstract][Full Text] [Related]
12. Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system.
Sölétormos G; Bach F
Clin Chem Lab Med; 2001 Feb; 39(2):170-2. PubMed ID: 11341753
[No Abstract] [Full Text] [Related]
13. Cerebrospinal fluid and serum IL-8, CCL2, and ICAM-1 concentrations in astrocytic brain tumor patients.
Koper OM; Kamińska J; Sawicki K; Reszeć J; Rutkowski R; Jadeszko M; Mariak Z; Dymicka-Piekarska V; Kemona H
Ir J Med Sci; 2018 Aug; 187(3):767-775. PubMed ID: 29086194
[TBL] [Abstract][Full Text] [Related]
14. Detection of biological activity in the cerebrospinal fluid of patients with central nervous system tumors.
Tapper D; Cahan MA; Brem H
J Neurooncol; 1994; 19(1):17-23. PubMed ID: 7815101
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
[TBL] [Abstract][Full Text] [Related]
16. Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid.
Ho CY; VandenBussche CJ; Huppman AR; Chaudhry R; Ali SZ
Cancer Cytopathol; 2015 Feb; 123(2):123-35. PubMed ID: 25487367
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer.
Bach F; Bjerregaard B; Sölétormos G; Bach FW; Horn T
Cancer; 1993 Oct; 72(8):2376-82. PubMed ID: 8402452
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
Kopkova A; Sana J; Fadrus P; Slaby O
Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
[TBL] [Abstract][Full Text] [Related]
19. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
20. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
Mattox AK; Yan H; Bettegowda C
Neuro Oncol; 2019 Dec; 21(12):1509-1518. PubMed ID: 31595305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
